- A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology
- Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease
- Cannabinoids and Dementia- A Review of Clinical and Preclinical Data
- Cannabinoids for the treatment of dementia
- Cannabinoids for treatment of Alzheimer’s disease- moving toward the clinic
- Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo_ relevance to Alzheimer’s disease
- Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
- Natural Phytochemicals in the Treatment and Prevention of Dementia- An Overview
- Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease
- Amyloid-beta inhibits E-S Potentiation through suppression of cannabinoid receptor 1 dependent synaptic disinhibition
- The influence of cannabinoids on generic traits of neurodegeneration
- The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease